acasti pharma stock price target

Presentation Operator MessageOperator Good day ladies and gentlemen and welcome to the Acasti Pharma Clinical and Business Update Conference Call. Is 149 for 2023 Mar.

Acst Stock Price And Chart Tsxv Acst Tradingview

2870 Owned Unlock Rating.

. Is 125 for 2026. Stock information by Barrons. As of 150 pm.

The 1 analysts offering price forecasts for Acasti Pharma have a median target of 600 with a high estimate of 600. View analyst opinion as to whether the stock is a strong buy strong sell or hold based on analyst 12-Month ACST price targets. Consumer Products Robert McWhirter.

ET by Tomi Kilgore Acasti Pharma downgraded to neutral from buy at B. According to analysts consensus price target of 600 Acasti Pharma has a forecasted upside of 5667 from its current price of 090. Acasti Pharma stock price target cut to 2 from 8 at B.

Stock forecast for 2022 2023 1 year - 2025 - 2027 5 year - 2030 and 2032 10 year Forecast for 2022 Apr. Nasdaq Acasti Pharma Inc. Close price at the end of the last trading day Friday 6th May 2022 of the ACST stock was 102.

Stock Price Forecast The 1 analysts offering 12-month price forecasts for Acasti Pharma Inc have a median target of 500 with a high estimate of 500 and a low estimate of 500. 65 Day Avg Vol 204677. Now that we know that Oppenheimer is bullish on ACST stock lets take a look at other analysts price targets.

Oppenheimer Initiates Coverage on Acasti Pharma With Outperform US6 TP. Shutterstock Today Oppenheimer initiated coverage on ACST stock with an outperform rating and a price target of 6. Assess the Acasti Pharma stock price estimates.

40 OFF - NEW YEAR SALE Get Our PREMIUM. Average price target from 1 ratings. Oppenheimer Adjusts Acasti Pharmas Price Target to 5 From 6 Maintains Outperform Ratin.

This price target is based on 1 analysts offering 12 month price targets for Acasti Pharma in the last 3 months. A phase 3 clinical trial showed tirzepatide to reduce A1C -- a key measure of average blood sugar levels -- better. Acasti Pharma Target Price Projection Acasti Pharmas current and average target prices are 113 and 600 respectively.

Rooms Shows Rankings Earnings. What are analysts forecasts for Acasti Pharma stock. According to the issued ratings of 1 analysts in the last year the consensus rating for Acasti Pharma stock is Buy based on the current 1 buy rating for ACST.

Amount of Analyst Coverage Acasti Pharma has received no research coverage in the past 90 days. Real-time trade and investing ideas on Acasti Pharma Inc - Ordinary Shares - Class A ACST from the largest community of traders and investors. Acasti Pharma Inc real time quote is equal to 1510 CAD at 2022-02-09 but your current investment may be devalued in the future.

Long term Acasti Pharma Inc. Complete Acasti Pharma Inc. This is 097 less than the trading day before Thursday 5th May 2022.

BUY Acasti Pharma ACST-X. Oppenheimer Adjusts Acasti Pharmas Price Target to 5 From 6 Maintains Outperform Ra. View real-time ACST stock price and news along with industry-best analysis.

Acasti Pharma Price Predictions HC Wainwright Co. UNOFFICIAL CLOSE 400 PM EDT 042522. The average price target is 600 with a high forecast of 600 and a low.

1y Target Est 489 Fair Value is the appropriate price for the shares of a company based on its earnings and growth rate also interpreted as when PE Ratio Growth Rate. The current price of Acasti Pharma is the price at which Acasti. 14 2020 at 856 am.

He sees a 10 target price if the result is good and all goes well. The average twelve-month price target for Acasti Pharma is 600 with a high price target of 600 and a low price target of 600. Learn more on ACSTs analyst rating history.

ET Eli Lillys stock price was up more than 3.

Onconova Therapeutics Inc Stock Completed Its Downtrend Ontx Stock Onconova Global Economy Stock Market Nasdaq